Taltz (Ixekizumab) is a biologic medicine that suppresses the immune system in order to treat psoriatic arthritis and psoriasis.
Taltz works by blocking a signalling protein (called a cytokine) named interleukin-17 (IL-17). IL-17 regulates the body's immune system and is related to its inflammatory response.
Taltz is available as a subcutaneous (under the skin) injection that can be administered at home.
The manufacturer of Taltz offers a support program to Canadian patients that are prescribed the medication:Patient support program enrolment forms
Important Tests and Risks
Drug Identification Number (DIN)